Studies have shown that improvements following LcS treatment on DSS-induced chronic colitis were associated with a decrease in IFN-γ production and an increase in IL-4 production in LI-LPMC, when stimulated with CD3ε/CD28 [18]. This evidence concerns the gene CD28 and Chronic colitis.